from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2312/-

LFCtreatmentdescriptionclass of inhibitor

-0.060

Amikacinug/mL Amikacintranslation

0.409

Cap5-10ug/mL Capreomycintranslation

0.773

Rox10-50 ug/mL Roxithromycintranslation

-0.236

SM2-5 ug/mL Streptomycintranslation

0.688

Tet5-10 ug/mL Tetracyclinetranslation

0.703

Rif0.2-5ug/mL Rifampicintranscription

-0.688

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.028

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.354

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.349

CPZ10-50 ug/mL Chlorpromazinerespiration

0.512

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.061

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.902

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.466

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.208

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.074

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.463

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.374

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.083

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.345

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.156

KCN5-20 ug/mL Potassium cyaniderespiration

-0.102

NaN30.2-2 mM Sodium aziderespiration

-1.122

Nigericin50 uM Nigericinrespiration

0.911

TRC10-150 ug/mL Triclosanrespiration

0.265

TRZ10-25 ug/mL Thioridazinerespiration

0.360

Valinomycin0.5-10 uM Valinomycinrespiration

-1.687

ZnSO42 mM ZnSO4respiration

-0.003

menadione6-10 ug/mL Menadionerespiration

0.305

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.160

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.085

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.472

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.405

NRP_1Non-replicating persistence stage 1dosRassociated

-0.343

Amp0.2mg/mL AmpicillincellWall

0.292

Cephalexin20-100 ug/mL CephalexincellWall

0.396

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.105

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.351

EMB10-20 ug/mL EthambutolcellWall

-0.127

Eta12-40 ug/mL EthionamidecellWall

-0.119

INH0.2-0.4 ug/mL IsoniazidcellWall

0.008

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.166

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.309

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.856

BZA0.12 mg/mL BenzamidearomaticAmides

-0.867

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.281

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.068

H2O24 mM hydrogen peroxideDNAdamaging

0.455

Levo10 ug/mL LevofloxacinDNAdamaging

0.048

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.716

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.224

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.586

UVUV-irradiationDNAdamaging

1.309

ARP41-4 ug/mL Antitubercular compound ARP4?

0.317

Antimycin12.5-50 ug/mL Antimycin A?

-1.718

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.350

PA_110-50 ug/mL Antitubercular compound PA-1?

0.106

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.653

PA8240.2-2 ug/mL PA-824?

0.384

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.302

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-2.063

Verapamil50 uM Verapamil?

-2.275

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.815

methoxatin10-20 ug/mL Methoxatin?